CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase I Trial of Bispecific Anti-CD19, Anti-CD20 CAR T Cells for B Cell Malignancies
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT07166549
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:45.101888+00:00
- Published At
- 2025-12-24T00:00:00+00:00
- Record Updated At
- 2025-12-24
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["B Cell Malignancies", "B-cell Leukemia", "B Cell Lymphoma", "Bispecific Chimeric Antigen Receptor (CAR) T Cells", "Relapsed or Refractory (r/r) B-cell Malignancies"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-12-24"- protocolSection.identificationModule.nctId
"NCT07166549"- protocolSection.identificationModule.officialTitle
"A Phase I Trial of Bispecific Anti-CD19, Anti-CD20 CAR T Cells for B Cell Malignancies"- protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.